SEIZE THE $50 BILLION SITE-OF-CARE SHIFT OPPORTUNITY
Get the tools, data, and insights to drive growth.
Learn more
RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Library

| Daily Briefing

Weekly review: Why Fauci is warning of another potential coronavirus surge


Why "covert vaccinees" are keeping their vaccine status a secret, whether blue light glasses really work, and more.

Why Fauci is warning of another potential coronavirus surge (Monday, March 15)

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, last week said Europe's recent surge in cases of the novel coronavirus should serve as a warning for the United States.

Why 'covert vaccinees' are keeping their vaccine status a secret (Tuesday, March 16)

Writing for The Atlantic, Katherine Wu profiles 12 people who have received the Covid-19 vaccine but opted to keep their newly vaccinated status a secret—revealing "a harrowing form of eligibility warfare" that could contribute to people's reluctance to get vaccinated at all.

'Like I wasn't there': What it's like to survive 'locked-in syndrome' (Wednesday, March 17)

Jake Haendel suffered for months from "locked-in syndrome," a rare phenomenon in which a patient is unable to move or communicate but remains fully conscious. But unlike most locked-in patients, Haendel recovered—and now he's sharing his experience, Josh Wilbur writes for The Guardian.

Blue light glasses are booming—but do they really work? (Thursday, March 18)

As more people spend their entire work day in front of a computer, sales of blue light glasses—which incorporate special lenses that filter out certain light waves emitted by digital devices—have boomed. But do these glasses actually reduce eye strain or improve sleep?

Map: The states with the highest (and lowest) vaccine completion rates (Friday, March 19)

New CDC research indicates that the vast majority of Americans who have received their first Covid-19 vaccine shot returned to receive their second shot—but there were some significant caveats. Find out how your state is faring on our interactive map.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.